EUVIMEDEUVIMED entdecken
EditorialKommentar

Is it time for bone marrow sparing radiation therapy to be standard of care in cervical cancer?

Diandra N Ayala-Peacock iD, Junzo P Chino iD

Cancer · 2023

DOI: 10.1002/cncr.34769 ↗

Kurz gefasst

Editorial in der Zeitschrift Cancer, 2023. Verfasst von Diandra N Ayala-Peacock und 1 weiteren Autor:innen. Beteiligte Einrichtung: Duke Cancer Institute, Raleigh and Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Radiation Injuries, Radiotherapy, Intensity-Modulated. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Evaluating a recent prospective trial of active bone marrow sparing defined by 99 mTc‐single‐photon emission computed tomography imaging in the landscape of the existing literature.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsRadiation InjuriesRadiotherapy, Intensity-ModulatedFemaleHumansBone MarrowStandard of CareCisplatinRadiotherapy DosageRadiotherapy Planning, Computer-Assisted

Substanzen

Cisplatin

Autor:innen und Institutionen

  • Duke Cancer Institute, Raleigh and Durham, North Carolina, USA.
  • Department of Radiation Oncology, Duke University School of Medicine, Durham, North Carolina, USA.

ORCID-Profile: Diandra N Ayala-Peacock, Junzo P Chino

Zitieren

APA

Ayala-Peacock, D. N., & Chino, J. P. (2023). Is it time for bone marrow sparing radiation therapy to be standard of care in cervical cancer?. Cancer. https://doi.org/10.1002/cncr.34769

Vancouver

Ayala-Peacock DN, Chino JP. Is it time for bone marrow sparing radiation therapy to be standard of care in cervical cancer?. Cancer. 2023. doi:10.1002/cncr.34769

BibTeX
@article{AyalaPeacock2023,
  author = {Ayala-Peacock, Diandra N and Chino, Junzo P},
  title = {Is it time for bone marrow sparing radiation therapy to be standard of care in cervical cancer?},
  journal = {Cancer},
  year = {2023},
  doi = {10.1002/cncr.34769}
}
Kostenlos starten →